Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease

dc.contributor.authorKaur, Satinder
dc.contributor.authorSehrawat, Abhishek
dc.contributor.authorMastana, Sarabjit Singh
dc.contributor.authorKandimalla, Ramesh
dc.contributor.authorSharma, Pushpender Kumar
dc.contributor.authorBhatti, Gurjit Kaur
dc.contributor.authorBhatti, Jasvinder Singh
dc.date.accessioned2024-01-21T10:54:16Z
dc.date.accessioned2024-08-14T07:41:00Z
dc.date.available2024-01-21T10:54:16Z
dc.date.available2024-08-14T07:41:00Z
dc.date.issued2023-08-02T00:00:00
dc.description.abstractParkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor symptoms such as tremors, rigidity, and bradykinesia. Current therapeutic strategies for PD are limited and mainly involve symptomatic relief, with no available treatment for the underlying causes of the disease. Therefore, there is a need for new therapeutic approaches that target the underlying pathophysiological mechanisms of PD. Calcium homeostasis is an essential process for maintaining proper cellular function and survival, including neuronal cells. Calcium dysregulation is also observed in various organelles, including the endoplasmic reticulum (ER), mitochondria, and lysosomes, resulting in organelle dysfunction and impaired inter-organelle communication. The ER, as the primary calcium reservoir, is responsible for folding proteins and maintaining calcium homeostasis, and its dysregulation can lead to protein misfolding and neurodegeneration. The crosstalk between ER and mitochondrial calcium signaling is disrupted in PD, leading to neuronal dysfunction and death. In addition, a lethal network of calcium cytotoxicity utilizes mitochondria, ER and lysosome to destroy neurons. This review article focused on the complex role of calcium dysregulation and its role in aggravating functioning of organelles in PD so as to provide new insight into therapeutic strategies for treating this disease. Targeting dysfunctional organelles, such as the ER and mitochondria and lysosomes and whole network of calcium dyshomeostasis can restore proper calcium homeostasis and improve neuronal function. Additionally targeting calcium dyshomeostasis that arises from miscommunication between several organelles can be targeted so that therapeutic effects of calcium are realised in whole cellular territory. � 2023 Elsevier Inc.en_US
dc.identifier.doi10.1016/j.lfs.2023.121995
dc.identifier.issn243205
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/4262
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0024320523006306
dc.language.isoen_USen_US
dc.publisherElsevier Inc.en_US
dc.subjectCalcium homeostasisen_US
dc.subjectER-mitochondria calcium signalingen_US
dc.subjectOrganelle crosstalken_US
dc.subjectParkinson's diseaseen_US
dc.subjectTherapeutic strategiesen_US
dc.titleTargeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's diseaseen_US
dc.title.journalLife Sciencesen_US
dc.typeReviewen_US
dc.type.accesstypeClosed Accessen_US

Files